MedTrace Logo

Parathyroid Hormone Kinetics During CRRT

NCT03873675 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2022-01-14

No results posted yet for this study

Summary

The objective of this study is to assess the parathyroid hormone serum concentrations and kinetics in critically ill patients admitted to the intensive care unit due to multi-organ failure and undergoing citrate anticoagulation continuous renal replacement therapy.

Conditions

Interventions

DIAGNOSTIC_TEST

parathyroid hormone

10-20ml blood samples taken from the arterial catheter every 12 hours to obtain parathyroid hormone serum concentration. 6-8 samples per patient

Sponsors & Collaborators

  • Uniwersytecki Szpital Kliniczny w Opolu

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-06
Primary Completion
2020-10-01
Completion
2020-11-01

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03873675 on ClinicalTrials.gov